Evidence map›Paper›PMID 37313811›Full record

ArticleNan fang yi ke da xue xue bao = Journal of Southern Medical University2023

[RITA selectively inhibits proliferation of

W Shi, X Liu, G Zhang, L Ye, R Zhou, Y Li, L Yu

Open access · greenAbstract readEnglish Abstract
PubMed Full text at PMC Publisher
In one paragraph

Article in Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

W ShiInnovative Group in Drug Design and Discovery Research, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China.
X LiuClinical Pharmacy Center, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
G ZhangInnovative Group in Drug Design and Discovery Research, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China.
L YeClinical Pharmacy Center, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
R ZhouInnovative Group in Drug Design and Discovery Research, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China.
Y LiClinical Pharmacy Center, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
L YuInnovative Group in Drug Design and Discovery Research, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China.
Nanfang Hospital · CNSouthern Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo screen for small molecular compounds with selective inhibitory activity against cutaneous melanoma cells with

methodsCutaneous melanoma cells expressing wild-type

resultsThe p53 activator RITA from the compound library was shown to selectively inhibit the viability of

conclusionLoss of

Indexed as

MelanomaSkin NeoplasmsApoptosisCell DivisionHumansTumor Suppressor Protein p53Tumor Suppressor ProteinsUbiquitin ThiolesteraseBAP1 protein, humanTumor Suppressor Protein p53Tumor Suppressor ProteinsUbiquitin ThiolesteraseapoptosisBAP1cell cyclecutaneous melanomap53RITA

Identifiers

PMID37313811
PMCPMC10267227
OpenAlexW4380577590

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.